NCT00396032View on ClinicalTrials.gov

A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2008

Conditions
Dysfunctional Hemodialysis Catheters
Interventions
DRUG

placebo

For the initial treatment, 2 mL of placebo instilled into each lumen of the HD catheter; subsequent treatments were 2 mL of open-label tenecteplase

DRUG

tenecteplase

For the initial treatment, 2 mL of reconstituted lyophilized tenecteplase instilled into each lumen of the HD catheter; subsequent treatments were 2 mL of open-label tenecteplase

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY